Patterns of colorectal cancer care in the United States and Canada: a systematic review.

Colorectal cancer is the third most common cancer in the United States and Canada. Given the high incidence and increased survival of colorectal cancer patients, prevalence is increasing over time in both countries. Using MEDLINE, we conducted a systematic review of the literature published between 2000 and 2010 to describe patterns of colorectal cancer care. Specifically we examined data sources used to obtain treatment information and compared patterns of cancer-directed initial care, post-diagnostic surveillance care, and end-of-life care among colorectal cancer patients diagnosed in the United States and Canada. Receipt of initial treatment for colorectal cancer was associated with the anatomical position of the tumor and extent of disease at diagnosis, in accordance with consensus-based guidelines. Overall, care trends were similar between the United States and Canada; however, we observed differences with respect to data sources used to measure treatment receipt. Differences were also present between study populations within country, further limiting direct comparisons. Findings from this review will allow researchers, clinicians, and policy makers to evaluate treatment receipt by patient, clinical, or system characteristics and identify emerging trends over time. Furthermore, comparisons between health-care systems in the United States and Canada can identify disparities in care, allow the evaluation of different models of care, and highlight issues regarding the utility of existing data sources to estimate national patterns of care.

[1]  J. Guillem,et al.  Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. , 1998, International journal of radiation oncology, biology, physics.

[2]  Mireya Diaz,et al.  Failure to screen: predictors and burden of emergency colorectal cancer resection. , 2007, The American journal of managed care.

[3]  S. Gallinger,et al.  Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.

[4]  C. Earle,et al.  Trends in healthcare utilization among older Americans with colorectal cancer: A retrospective database analysis , 2009, BMC health services research.

[5]  J. Birkmeyer,et al.  Racial disparities in late survival after rectal cancer surgery. , 2006, Journal of the American College of Surgeons.

[6]  L. Påhlman Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Commentary , 2001 .

[7]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[8]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[9]  N. Baxter,et al.  Variability in Reconstructive Procedures Following Rectal Cancer Surgery in the United States , 2010, Diseases of the colon and rectum.

[10]  Deborah Schrag,et al.  Building capacity to assess cancer care in the Medicaid population in New York State. , 2011, Health services research.

[11]  J. Niland,et al.  Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

[12]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[13]  J. Wong,et al.  The Use of Pelvic Radiation in Stage II Rectal Cancer: A Population-Based Analysis , 2010, The American surgeon.

[14]  C. Begg,et al.  Age and adjuvant chemotherapy use after surgery for stage III colon cancer. , 2001, Journal of the National Cancer Institute.

[15]  K. Knopf,et al.  Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. , 2003, Health services research.

[16]  S. Hendren,et al.  Surgical Complications Are Associated With Omission of Chemotherapy for Stage III Colorectal Cancer , 2010, Diseases of the colon and rectum.

[17]  P. T. Phang,et al.  Practice patterns and appropriateness of rectal cancer management in , 2003 .

[18]  G. Cooper,et al.  Receipt of guideline‐recommended follow‐up in older colorectal cancer survivors , 2008, Cancer.

[19]  E. Ossiander,et al.  Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum , 2002, Cancer.

[20]  Deborah Schrag,et al.  The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.

[21]  P. Loehrer Completion of Therapy by Medicare Patients With Stage III Colon Cancer , 2007 .

[22]  E. McCarthy,et al.  Dying with Cancer: Patients' Function, Symptoms, and Care Preferences as Death Approaches , 2000, Journal of the American Geriatrics Society.

[23]  J. Goodwin,et al.  Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. , 2006, The oncologist.

[24]  D. Schwartz,et al.  Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population , 2008, Cancer.

[25]  R. Cress,et al.  Use of Surgical Procedures and Adjuvant Therapy in Rectal Cancer Treatment: A Population-Based Study , 2001, Annals of surgery.

[26]  T. Ben-Menachem,et al.  Sociodemographic Differences in the Receipt of Colorectal Cancer Surveillance Care Following Treatment With Curative Intent , 2001, Medical care.

[27]  D. Rothenberger,et al.  The Status of Radical Proctectomy and Sphincter-Sparing Surgery in the United States , 2007, Diseases of the colon and rectum.

[28]  J. Lynn,et al.  Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents. , 2007, Journal of women's health.

[29]  A. Morris,et al.  Adjuvant Radiation for Rectal Cancer: Do We Measure Up to the Standard of Care? An Epidemiologic Analysis of Trends Over 25 Years in the United States , 2005, Diseases of the colon and rectum.

[30]  M. Winget,et al.  Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. , 2009, Clinical colorectal cancer.

[31]  K. Hardiman,et al.  Disparities in the treatment of colon cancer in octogenarians. , 2009, American journal of surgery.

[32]  J. Warren,et al.  Patterns of colorectal cancer care in Europe, Australia, and New Zealand. , 2013, Journal of the National Cancer Institute. Monographs.

[33]  Xiaocheng Wu,et al.  Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana. , 2004, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.

[34]  Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer , 2009, Journal of surgical oncology.

[35]  B. Minsky Sphincter preservation in rectal cancer , 1999, International Journal of Clinical Oncology.

[36]  M. Jankowski,et al.  Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. , 2005, Journal of the National Cancer Institute. Monographs.

[37]  E. Feuer,et al.  Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. , 2001, Gastrointestinal endoscopy.

[38]  C. Begg,et al.  Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  A. Chak,et al.  Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer. , 2000, Gastrointestinal endoscopy.

[40]  K. Kozak,et al.  External beam radiotherapy for colon cancer: patterns of care. , 2010, International journal of radiation oncology, biology, physics.

[41]  Karla Kerlikowske,et al.  Trends in Colonoscopy for Colorectal Cancer Screening , 2007, Medical care.

[42]  E. Wagner,et al.  Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. , 2004, Gastrointestinal endoscopy.

[43]  T. To,et al.  Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population , 2000, Journal of Gastrointestinal Surgery.

[44]  J. Krischer,et al.  Effects of health insurance and race on colorectal cancer treatments and outcomes. , 2000, American journal of public health.

[45]  A. Neugut,et al.  Survival Associated with 5-FluorouracilBased Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer , 2002, Annals of Internal Medicine.

[46]  E. Lamont,et al.  End‐of‐life care for older cancer patients in the Veterans Health Administration versus the private sector , 2010, Cancer.

[47]  H. Au,et al.  Ageism in rectal carcinoma? , 2002, International journal of gastrointestinal cancer.

[48]  Laura-Mae Baldwin,et al.  Residual treatment disparities after oncology referral for rectal cancer. , 2008, Journal of the National Cancer Institute.

[49]  M. Winget,et al.  Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline‐recommended treatment , 2010, Cancer.

[50]  C. Lynch,et al.  Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  A. Morris,et al.  Racial disparities in rectal cancer treatment: a population-based analysis. , 2004, Archives of surgery.

[52]  P. Loehrer Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly , 2007 .

[53]  A. Neugut,et al.  Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. , 2001, Cancer journal.

[54]  S. Gill,et al.  Primary Tumor Resection in Patients Presenting With Metastatic Colorectal Cancer: Analysis of a Provincial Population-Based Cohort , 2010, American journal of clinical oncology.

[55]  W. Barlow,et al.  Explaining black-white differences in receipt of recommended colon cancer treatment. , 2005, Journal of the National Cancer Institute.

[56]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[57]  Harry B. Spencer,et al.  At the State Level , 1955 .

[58]  L. Clegg,et al.  Patterns of Care for Adjuvant Therapy in a Random Population-Based Sample of Patients Diagnosed with Colorectal Cancer , 2006, The American Journal of Gastroenterology.

[59]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[60]  R. Single,et al.  Surgical Resection of Primary Tumors in Patients Who Present With Stage IV Colorectal Cancer: An Analysis of Surveillance, Epidemiology, and End Results Data, 1988 to 2000 , 2005, Annals of Surgical Oncology.

[61]  P. Stang,et al.  Treatment and Referral Patterns for Colorectal Cancer , 2004, Medical care.

[62]  A. Neugut,et al.  Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  G. Cooper,et al.  Temporal trends in colorectal procedure use after colorectal cancer resection. , 2006, Gastrointestinal endoscopy.

[64]  Charles W. Given,et al.  Medicaid, Medicare, and the Michigan Tumor Registry: A Linkage Strategy , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

[65]  E. Elkin,et al.  Cancer's next frontier: addressing high and increasing costs. , 2010, JAMA.

[66]  D. Turner,et al.  Local recurrence after rectal cancer treatment in Manitoba. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.

[67]  C. Earle,et al.  Trends in Follow-up and Preventive Care for Colorectal Cancer Survivors , 2008, Journal of General Internal Medicine.

[68]  L. Temple,et al.  Use of surgery among elderly patients with stage IV colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  R. Pietrobon,et al.  Relationship Between Surgeon Caseload and Sphincter Preservation in Patients With Rectal Cancer , 2005, Diseases of the colon and rectum.

[70]  Laura-Mae Baldwin,et al.  Completion of therapy by Medicare patients with stage III colon cancer. , 2006, Journal of the National Cancer Institute.

[71]  A. Stewart,et al.  Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. , 2005, JAMA.

[72]  J. Skibber,et al.  Are We Undertreating Rectal Cancer in the Elderly?: An Epidemiologic Study , 2007, Annals of surgery.

[73]  Xianglin L. Du,et al.  Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002 , 2008, Cancer.

[74]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[75]  R. Peto,et al.  Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials , 2001, The Lancet.

[76]  C. Ko,et al.  A Patient's Race/Ethnicity Does Not Explain the Underuse of Appropriate Adjuvant Therapy in Colorectal Cancer , 2006, Diseases of the colon and rectum.

[77]  T. Fitzgerald,et al.  Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. , 2008, Archives of internal medicine.

[78]  A. Stewart,et al.  Age-, Race-, and Ethnicity-Related Differences in the Treatment of Nonmetastatic Rectal Cancer: A Patterns of Care Study From the National Cancer Data Base , 2008, Annals of Surgical Oncology.

[79]  M. Pisu,et al.  Less-than-standard treatment in rectal cancer patients: which patients are at risk? , 2010, Journal of the National Medical Association.

[80]  E. Emanuel,et al.  Chemotherapy Use among Medicare Beneficiaries at the End of Life , 2003, Annals of Internal Medicine.

[81]  A. Neugut,et al.  Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer. , 2009, Journal of the National Cancer Institute.

[82]  R. Hilsden,et al.  A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province , 2004, BMC Cancer.

[83]  G. Pond,et al.  Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer. , 2008, Clinical colorectal cancer.

[84]  W. Chapman,et al.  Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. , 2002, Archives of surgery.

[85]  A. Neugut,et al.  Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  Joseph Lipscomb,et al.  State-Level Cancer Quality Assessment and Research: Building and Sustaining the Data Infrastructure , 2011, Cancer journal.

[87]  C. Earle,et al.  Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States , 2010, BMC health services research.

[88]  D. Turner,et al.  Survival and treatment trends of rectal cancer patients in a population with suboptimal local control. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[89]  C. Becerra,et al.  Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. , 2010, Clinical colorectal cancer.

[90]  Xianglin L. Du,et al.  Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  J. Meza,et al.  Temporal and Regional Variations in the Use of Preoperative Radiation Therapy for Rectal Cancer , 2010, American journal of clinical oncology.

[92]  Ma Dong,et al.  Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .

[93]  Deborah Schrag,et al.  Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.

[94]  A. Zaslavsky,et al.  Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[95]  J. Guillem,et al.  Young Age Influences Treatment but not Outcome of Colon Cancer , 2007, Annals of Surgical Oncology.

[96]  E. Guadagnoli,et al.  Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? , 2005, Journal of the National Cancer Institute.